%0 Journal Article
%T Mild Cognitive Impairment in Parkinson¡¯s Disease: A Review of Current Concepts
%A Natalie C. Palavra
%A Sharon L. Naismith
%A Simon J. G. Lewis
%J Neurology Research International
%D 2013
%I Hindawi Publishing Corporation
%R 10.1155/2013/576091
%X Mild Cognitive Impairment in Parkinson¡¯s Disease (PD-MCI) is common and may be associated with accelerated progression to dementia. Considering the importance of this emerging entity, new diagnostic criteria have recently been proposed. Early recognition and accurate classification of PD-MCI could offer opportunities for novel therapeutic interventions. This review discusses current definitions for PD-MCI, the screening tools used, the pattern of cognitive deficits observed, and the predictors of cognitive decline and transition to Parkinson¡¯s Disease Dementia. Emerging biomarkers, which may aid diagnosis, are also explored and the role of novel treatment options is considered. 1. Introduction Idiopathic Parkinson¡¯s Disease (PD) is a progressive neurodegenerative disorder typically characterised by its motor features: bradykinesia, tremor, rigidity, and postural instability. However, it has become increasingly apparent that nonmotor features such as cognitive impairment, constipation, bladder dysfunction, sleep disorders, depression, anxiety, and psychosis are also significant [1]. Indeed, these symptoms, which are often poorly recognised and treated, can dominate in advanced PD accounting for significant disability, impaired quality of life, and reduced life expectancy [1, 2]. Cognitive impairment is particularly prevalent in PD and varies from mild deficits through to severe dementia [3]. Usually, dementia is limited to the advanced stages of disease, but it affects over 80% of those with 20 years of disease [4]. By contrast, subtle cognitive impairment is common in early disease and one study has reported that over a third of patients have deficits at the time of their diagnosis [5]. Importantly, even these subtle impairments impact on quality of life [6], exacerbate caregiver distress [7], and increase the risk of nursing home placement [8]. These impairments are likely to herald the progression to dementia [9, 10] and thus the early recognition of cognitive impairment could offer a window for novel therapeutic interventions, aiming to alter the course of this natural history [11]. 2. Defining Mild Cognitive Impairment In nonPD populations, Mild Cognitive Impairment (MCI) describes an intermediate stage between normal cognitive function and dementia [11], where an individual has deficits in at least one cognitive domain [12]. Diagnostic criteria have been proposed by Petersen [13], wherein MCI is characterised by a deficit of at least 1.5 standard deviations (SD) below that expected for an individual¡¯s age and education level. Unlike the presence of
%U http://www.hindawi.com/journals/nri/2013/576091/